CORPAY INC (CPAY) Fundamental Analysis & Valuation

NYSE:CPAY • US2199481068

Current stock price

341.99 USD
+4.65 (+1.38%)
Last:

This CPAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPAY Profitability Analysis

1.1 Basic Checks

  • In the past year CPAY was profitable.
  • In the past year CPAY had a positive cash flow from operations.
  • CPAY had positive earnings in each of the past 5 years.
  • CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CPAY has a Return On Assets of 4.05%. This is in the better half of the industry: CPAY outperforms 73.74% of its industry peers.
  • CPAY's Return On Equity of 27.55% is amongst the best of the industry. CPAY outperforms 92.93% of its industry peers.
  • CPAY has a Return On Invested Capital of 9.95%. This is amongst the best in the industry. CPAY outperforms 81.82% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPAY is above the industry average of 8.00%.
Industry RankSector Rank
ROA 4.05%
ROE 27.55%
ROIC 9.95%
ROA(3y)5.33%
ROA(5y)5.8%
ROE(3y)29.87%
ROE(5y)31.29%
ROIC(3y)11.18%
ROIC(5y)11.44%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 23.62%, CPAY belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CPAY has declined.
  • Looking at the Operating Margin, with a value of 43.10%, CPAY belongs to the top of the industry, outperforming 82.83% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
  • With an excellent Gross Margin value of 78.60%, CPAY belongs to the best of the industry, outperforming 83.84% of the companies in the same industry.
Industry RankSector Rank
OM 43.1%
PM (TTM) 23.62%
GM 78.6%
OM growth 3Y0.7%
OM growth 5Y1.15%
PM growth 3Y-5.33%
PM growth 5Y-4.33%
GM growth 3YN/A
GM growth 5YN/A
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CPAY Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPAY is still creating some value.
  • CPAY has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CPAY has been reduced compared to 5 years ago.
  • The debt/assets ratio for CPAY has been reduced compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that CPAY is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CPAY (1.54) is better than 71.72% of its industry peers.
  • The Debt to FCF ratio of CPAY is 7.70, which is on the high side as it means it would take CPAY, 7.70 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.70, CPAY is in line with its industry, outperforming 57.58% of the companies in the same industry.
  • A Debt/Equity ratio of 2.18 is on the high side and indicates that CPAY has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.18, CPAY is doing worse than 67.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF 7.7
Altman-Z 1.54
ROIC/WACC1.33
WACC7.46%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • CPAY has a Current Ratio of 0.98. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.98, CPAY perfoms like the industry average, outperforming 50.51% of the companies in the same industry.
  • CPAY has a Quick Ratio of 0.98. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, CPAY is in line with its industry, outperforming 50.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CPAY Growth Analysis

3.1 Past

  • CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.47%, which is quite good.
  • Measured over the past years, CPAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.03% on average per year.
  • CPAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.93%.
  • The Revenue has been growing by 13.64% on average over the past years. This is quite good.
EPS 1Y (TTM)12.47%
EPS 3Y9.92%
EPS 5Y14.03%
EPS Q2Q%12.69%
Revenue 1Y (TTM)13.93%
Revenue growth 3Y9.73%
Revenue growth 5Y13.64%
Sales Q2Q%20.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.89% on average over the next years. This is quite good.
  • CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.72% yearly.
EPS Next Y23.59%
EPS Next 2Y18.99%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue Next Year16.63%
Revenue Next 2Y13.5%
Revenue Next 3Y12.11%
Revenue Next 5Y10.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

6

4. CPAY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.00, the valuation of CPAY can be described as correct.
  • The rest of the industry has a similar Price/Earnings ratio as CPAY.
  • CPAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.95.
  • CPAY is valuated correctly with a Price/Forward Earnings ratio of 12.94.
  • CPAY's Price/Forward Earnings is on the same level as the industry average.
  • CPAY is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16
Fwd PE 12.94
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 64.65% of the companies in the same industry are more expensive than CPAY, based on the Enterprise Value to EBITDA ratio.
  • CPAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 64.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.41
EV/EBITDA 11.94
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 -100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CPAY may justify a higher PE ratio.
  • CPAY's earnings are expected to grow with 17.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)1.14
EPS Next 2Y18.99%
EPS Next 3Y17.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CPAY Dividend Analysis

5.1 Amount

  • CPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CPAY Fundamentals: All Metrics, Ratios and Statistics

CORPAY INC

NYSE:CPAY (4/21/2026, 9:35:56 AM)

341.99

+4.65 (+1.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners97.3%
Inst Owner Change0.32%
Ins Owners3.67%
Ins Owner Change0.13%
Market Cap22.62B
Revenue(TTM)4.53B
Net Income(TTM)1.07B
Analysts83.64
Price Target389.81 (13.98%)
Short Float %3.7%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.66%
Min EPS beat(2)-0.95%
Max EPS beat(2)-0.36%
EPS beat(4)0
Avg EPS beat(4)-1.28%
Min EPS beat(4)-2.03%
Max EPS beat(4)-0.36%
EPS beat(8)0
Avg EPS beat(8)-1.4%
EPS beat(12)1
Avg EPS beat(12)-1.39%
EPS beat(16)4
Avg EPS beat(16)-0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.06%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.93%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-1.96%
Revenue beat(12)1
Avg Revenue beat(12)-2.1%
Revenue beat(16)3
Avg Revenue beat(16)-1.34%
PT rev (1m)0.49%
PT rev (3m)7.54%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.28%
EPS NY rev (3m)4.68%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 16
Fwd PE 12.94
P/S 4.99
P/FCF 17.41
P/OCF 15.08
P/B 5.82
P/tB N/A
EV/EBITDA 11.94
EPS(TTM)21.38
EY6.25%
EPS(NY)26.42
Fwd EY7.73%
FCF(TTM)19.65
FCFY5.74%
OCF(TTM)22.68
OCFY6.63%
SpS68.48
BVpS58.73
TBVpS-104.62
PEG (NY)0.68
PEG (5Y)1.14
Graham Number168.085 (-50.85%)
Profitability
Industry RankSector Rank
ROA 4.05%
ROE 27.55%
ROCE 16.12%
ROIC 9.95%
ROICexc 12.12%
ROICexgc 218.24%
OM 43.1%
PM (TTM) 23.62%
GM 78.6%
FCFM 28.69%
ROA(3y)5.33%
ROA(5y)5.8%
ROE(3y)29.87%
ROE(5y)31.29%
ROIC(3y)11.18%
ROIC(5y)11.44%
ROICexc(3y)13.22%
ROICexc(5y)13.72%
ROICexgc(3y)186.24%
ROICexgc(5y)N/A
ROCE(3y)18.08%
ROCE(5y)17.51%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-7.95%
ROICexc growth 5Y2%
OM growth 3Y0.7%
OM growth 5Y1.15%
PM growth 3Y-5.33%
PM growth 5Y-4.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF 7.7
Debt/EBITDA 3.62
Cap/Depr 51.04%
Cap/Sales 4.43%
Interest Coverage 3.97
Cash Conversion 63.96%
Profit Quality 121.44%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.54
F-Score6
WACC7.46%
ROIC/WACC1.33
Cap/Depr(3y)48.88%
Cap/Depr(5y)46.57%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.26%
Profit Quality(3y)165.21%
Profit Quality(5y)137.64%
High Growth Momentum
Growth
EPS 1Y (TTM)12.47%
EPS 3Y9.92%
EPS 5Y14.03%
EPS Q2Q%12.69%
EPS Next Y23.59%
EPS Next 2Y18.99%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue 1Y (TTM)13.93%
Revenue growth 3Y9.73%
Revenue growth 5Y13.64%
Sales Q2Q%20.67%
Revenue Next Year16.63%
Revenue Next 2Y13.5%
Revenue Next 3Y12.11%
Revenue Next 5Y10.72%
EBIT growth 1Y11.16%
EBIT growth 3Y10.5%
EBIT growth 5Y14.96%
EBIT Next Year42.93%
EBIT Next 3Y21.02%
EBIT Next 5YN/A
FCF growth 1Y-26.41%
FCF growth 3Y29.13%
FCF growth 5Y-1.4%
OCF growth 1Y-22.71%
OCF growth 3Y25.72%
OCF growth 5Y0.37%

CORPAY INC / CPAY Fundamental Analysis FAQ

What is the fundamental rating for CPAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to CPAY.


What is the valuation status for CPAY stock?

ChartMill assigns a valuation rating of 6 / 10 to CORPAY INC (CPAY). This can be considered as Fairly Valued.


What is the profitability of CPAY stock?

CORPAY INC (CPAY) has a profitability rating of 7 / 10.


What is the valuation of CORPAY INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CORPAY INC (CPAY) is 16 and the Price/Book (PB) ratio is 5.82.


How financially healthy is CORPAY INC?

The financial health rating of CORPAY INC (CPAY) is 3 / 10.